HyProCure® - A Real Solution for TaloTarsal Displacement

HyProCure^®, a Type II Extra-Osseous TaloTarsal Stabilization (EOTTS) device, has become the leading solution for patients suffering with the symptoms and secondary conditions resulting from partial talotarsal dislocation. The condition is a foot imbalance that throws both the foot and the entire body out of alignment. It affects people of all ages and is often the direct or contributing cause of overpronation, bunions, plantar fasciitis, knee pain, hip pain, back pain and even problems in the neck and shoulders.

The device is placed deep into the canalis portion of the sinus tarsi, reestablishing the normal pivot over which the talus (ankle bone) glides, thereby properly realigning the foot and ankle bones and restoring normal function. Via a minimally invasive procedure, the HyProCure^® device instantly stabilizes the hindfoot bones, stopping the continued trauma to the foot and body, and even possibly leading to the reversal of associated conditions.  HyProCure^® represents a real solution for talotarsal displacement and its devastating effects throughout the body.

Potential surgical candidates can find out more about the HyProCure^® solution and the devastating effects of talotarsal dislocation at www.HyProCure.com.

Contact us to learn more! 

Check out the Doctor Locator here.

Will I feel the implant in my foot?

No. As long as the implant does not displace, you should not be able to feel HyProCure^® after the procedure. Sometimes for the first few months a hard substance may be felt in the area of the surgery. This is scar tissue and should dissipate after several months, if present at all.

Learn more about the minimally invasive, life-changing procedure at www.HyProCure.com. Find a trained specialist on the Doctor Locator. 

Who Needs This Procedure?

If you or someone close to you suffers from the symptoms or secondary conditions caused by talotarsal displacement, the HyProCure^® procedure should be strongly considered as early as possible. The longer the condition is present, the more problematic the symptoms throughout the body can become.

Take a look at our symptoms and secondary conditions page to learn if partial talotarsal dislocation is affecting you, and learn how HyProCure^® can restore your quality of life by resolving the problem at its root.

If the HyProCure® procedure is performed on a child, does it have to be replaced later in life?

The short answer is likely no, but this is not a guarantee. Normally, once the stent is inserted into the foot it never has to be changed. The bones will continue to grow peripherally around HyProCure^®.

Learn more at www.HyProCure.com. Find a trained HyProCure^® Specialist on the Doctor Locator. 

Relief of Foot Pain & Increased Foot Function with Minimally Invasive Procedure

The Journal of Foot and Ankle Surgery (www.jfas.org) recently published a prospective, multi-centered study on subjective outcomes of patients who underwent an extraosseous talotarsal stabilization (EOTTS) procedure using the HyProCure^® Type II EOTTS device. In all cases, EOTTS was the only procedure performed. The outcomes showed results including improvement in foot pain and function. More importantly, for patients diagnosed with a secondary condition, including plantar fasciitis, posterior tibial tendon dysfunction (PTTD), bunions and hammertoes, the study showed alleviation of symptoms from these conditions without additional surgery.

The investigation was for patients diagnosed with recurrent and/or partial talotarsal joint dislocation (RTTD). With RTTD, the ankle bone displaces slightly on the heel bone and bones of the midfoot, creating a misalignment of forces throughout the foot and the lower extremities. This is generally a congenital condition. RTTD has been cited as a possible etiology for many foot ailments and can be the direct cause of numerous symptoms and secondary conditions, including fallen arches, plantar fasciitis (heel pain), overpronation/hyperpronation, bunions, heel spurs, knee pain, hip pain, back pain and even complications in the neck and shoulders.

The study involved 4 surgeons at 3 different facilities. Results were available for a total of 35 patients and 46 feet. Patients included both children and adults ranging in age from 8-72 years old. The mean age at the time of surgery was 41 years old. Subjective surveys were given pre-surgery and those answers/scores were compared to post-surgery evaluations at 1, 2 and 3 weeks, 1, 2, 3 and 6 months and at 1 year. The evaluation was done using the Maryland Foot Score assessment, a validated form that has been used in other studies.

The mean overall scores improved from a preoperative value of 69.53 to a postoperative value of 89.17 (out of 100) at the 1-year follow-up period. Foot pain was reported to be reduced by 36.97%, foot functional activities improved by 14.39%, and foot appearance improved by 29.49%.  The greatest magnitude of improvement occurred 4 weeks postoperatively, with gradual improvement continuing through to the 1-year follow-up. The implant removal rate was 4.35%, the lowest published rate for any EOTTS device.

Twenty-five feet in 21 (60%) patients were diagnosed with a secondary condition, including plantar fasciitis, PTTD, bunions and hammertoes. Though no additional procedures were performed to correct these pathologies, patients reported alleviation of symptoms from these secondary conditions.

The positive outcomes resulting from the study demonstrate that the extraosseous talotarsal stabilization procedure using the Type II HyProCure^® device alleviates pain and improves foot function and appearance in patients with RTTD.  HyProCure^® represents a real solution for flexible talotarsal dislocation and its devastating effects throughout the body.

To view the complete study abstract, please visit http://www.jfas.org/article/S1067-2516%2812%2900505-4/abs.... Find further research on the positive outcomes of EOTTS with HyProCure^® in the library section of http://www.GraMedica.com/.

Foot and ankle surgeons are invited to learn more about the HyProCure^® device and procedure at www.GraMedica.com, where they can also train online and/or find a live surgical training seminar in their area.

Potential surgical candidates, from around the world, can find out more about the HyProCure^® solution and the devastating effects of talotarsal displacement at www.HyProCure.com. Find a local HyProCure^® specialist through the physician locator at http://HyProCure.com/doctor-locator/.

HyProCure® Patients Find a Solution to Pain

Learn more at www.HyProCure.com.

Patient Testimonials - "No more foot pain!"

Take the opportunity to review our case studies and testimonials to learn how the HyProCure^® solution has helped others resolve their pain. Hear firsthand from our patients and physicians what the HyProCure^® procedure is like, the results they have found and how it has changed their quality of life.

Learn more at www.HyProCure.com.

HyProCure® Before & After TaloTarsal Stabilization

HyProCure^® is an internal talotarsal stabilization device. It restores the "joint" aligment of the talus on the hind-foot bones thus re-aligning the foot.



For more information please visit www.HyProCure.com.

Extra-osseous Talotarsal Stabilization - HyProCure®

Extra-osseous Talotarsal Stabilization - HyProCure: The Scientific Evidence is HERE! from GraMedica, GIII

Will there be a visible scar after my HyProCure® procedure?

The incision is less than an inch long and slender and this part of the skin heals remarkably well. With time, the scar should become virtually invisible, in most cases.

Learn more at www.HyProCure.com

EOTTS Type II - Non-arthroeresisis: HyProCure®

The Power of HyProCure® - one girl's story told in sand

New EOTTS Classification System Identifies HyProCure® as Having Better Design and Patient Outcomes

A recent study, Extra-Osseous Stabilization Devices: A New Classification System published in The Journal of Foot and Ankle Surgery, Volume 51, Issue 5, Pages 613-619, September 2012, provides a systematic approach to classifying the differences in design features and biomechanical function of Extra-Osseous TaloTarsal Stabilization (EOTTS) devices.

Read more >>>

To read the abstract of this study and find further research on the positive outcomes of EOTTS with HyProCure® visit the library section of http://www.GraMedica.com/.

Leading Chinese Foot and Ankle Surgeon Bestowed Title of GIII® 2012 “Game Changer”

The Game Changer Award is an esteemed recognition given by GIII^® and GraMedica^® to an individual who demonstrates a strong dedication and passion to improve the quality of life for patients suffering from the ill-effects of foot pathologies and who helps elevate the field of foot and ankle surgery.


GIII^® and GraMedica^® are pleased to recognize Dr. Zhang for his hard work and will continue to support his future endeavors to educate Chinese foot and ankle specialists on the treatment of foot and ankle conditions.

Read more.

Chinese Surgeons Trained in use of HyProCure® at 2012 TongRen Foot and Ankle Symposium

Specialists in attendance at China’s leading Foot and Ankle Symposium gained valuable education on the Extra-Osseous TaloTarsal Stabilization Procedure.

“The room was packed with surgeons, all with their cameras and video cameras, eager for their first foot cadaver course,” said Michael E. Graham, DPM, FACFAS, FAENS, founder of GraMedica^® and creator of HyProCure^®. “It was amazing to be involved in such a ground-breaking event.” Read more.

Changing Lives, One Step at a Time: HyProCure® Marks 8 Years

Over the past eight years, HyProCure^®, a Type II Extra-Osseous TaloTarsal Stabilization (EOTTS) device, has become the leading solution for patients suffering with the symptoms and secondary conditions resulting from partial talotarsal dislocation. TaloTarsal Displacement is a foot imbalance that throws both the foot and the entire body out of alignment. It affects people of all ages and is often the direct or contributing cause of overpronation, bunions, plantar fasciitis, knee pain, hip pain, back pain, and even problems in the neck and shoulders. Read more.

Creator of HyProCure® Educates Foot & Ankle Specialists Across China

In a recent journey throughout China, innovator of the life changing HyProCure^® procedure took time to educate surgeons, meet with patients and share his skills. Read more.

Is it Possible for HyProCure® to Displace?

Displacement / migration of the implant
Even though HyProCure^® is inserted correctly at the time of surgery, it is possible for it to shift or displace. Every sinus tarsi is different and HyProCure^® may need to “seek its own position.” The stent is only pushed into the sinus tarsi; it is not drilled or cemented. If displacement of the implant does occur, it almost always will happen within the first four weeks post-op. Although it is possible for it to displace after the four-week period, this is extremely rare.

If slight displacement does occur, the implant is holding correction, and the patient has no pain or discomfort, a revision is not needed. If there is loss of correction, the implant will have to be repositioned and the patient will have to be careful with the way he/she walks, etc., during the four to six weeks it takes for the tissues to hold the stent in place. It is possible that even with ideal placement surgically, along with optimum patient compliance, the implant will still displace and migrate. This is due to anatomical variations within the sinus tarsi and inability of the soft tissues to hold the implant in place.

Learn more here.

Have Questions about the HyProCure® procedure?

The best thing to do is consult with a HyProCure^® Specialist. Find one today on our Doctor Locator.

Have general questions? Visit our website and fill out our Contact Form.